x

¿Aún no está registrado?

Cree su cuenta. Regístrese en Elsevier y obtendrá: información relevante, máxima actualización y promociones exclusivas.

Registrarme ahora
Ayuda - - Regístrese - Teléfono 902 888 740
Buscar en

Indexada en:

Excerpta Medica/EMBASE, IBECS, IME, SCOPUS

Métricas

  • SCImago Journal Rank (SJR):0,12
  • Source Normalized Impact per Paper (SNIP):0,124
doi: 10.1016/S0210-573X(03)77232-3
Síndrome de blefarofimosis-ptosis-epicanto inverso tipo I
L.C. Tejerizo-López, A. Tejerizo-García, M.M. Sánchez, R.M. García-Robles, A. Leiva, E. Morán, F. Corredera
Departamento de Obstetricia y Ginecología. Hospital Virgen de la Vega. Salamanca. España.
Aceptado 03 julio 2001
Summary

Blepharophimosis-ptosis-epicanthus syndrome (BPES) is a rare genetic condition occurring sporadically and transmitted by autosomal dominant inheritance.

Type I BPES is associated with a high incidence of menstrual irregularities and infertility. Its clinical presentation is attributed to either ovarian resistance to gonadotrophins or to a true premature menopause. Two pathophysiological mechanisms are discussed. One suggests an initial process of inhibition of follicular development and an increase in the level of follicular atresia. The other hypothesis is a modification of genetic material situated independently on at least two different genes.

We report a familial case of BPES identified at birth, who required several surgical procedures. Several members of the patients family are also affected.

Genetic counselling is advised after diagnosis of BPES in a family. Women who are affected with this need adequate, early treatment to help with infertility.

Resumen

El síndrome de blefarofimosis-ptosis-epicanto inverso (SBPEI) es una afección genética rara transmitida de manera dominante.

El SBPEI de tipo I está asociado con una incidencia elevada de alteraciones menstruales y con esterilidad. La sintomatología se atribuye a una resistencia ovárica a las gonadotropinas o a una verdadera menopausia precoz. Se discuten dos mecanismos fisiopatológicos:uno implica un proceso inicial de inhibición del desarrollo de los folículos y un aumento de la tasa de atresia folicular; la otra hipótesis es una modificación del material genético situado sobre al menos dos genes independientes.

Aportamos un caso familiar de SBPEI de tipo I objetivado en el nacimiento y operado en numerosas ocasiones. Otros miembros de la familia están igualmente afectados.

Tras el diagnóstico de SBPEI en una familia está indicado el consejo genético. En este síndrome, el único tratamiento adecuado es un abordaje temprano, para poder ayudar a las pacientes infértiles.

El Texto completo solo esta disponible en PDF
Bibliografía
1.
N.I. Vignes
Epicanthus héréditarie
Rev Gen Ophtal, 8 (1889), pp. 438-442
2.
R. Jiménez Parras,L. Macías Molinero
Patología de los pár-pados. I.
Oftalmología, 2, pp. 85-95
3.
J. Zlotogora,M. Sagi,T. Cohen
The blepharophimosis, ptosis and epicanthus inversus syndrome: delineation of two types
Am J Hum Genet, 35 (1983), pp. 1020-1027
4.
P.S. De Harper,J. Frezal,M.A. Ferguson-Smith
Report of the committee on clinical disorders and chromosomal syndromes. Human Gene Mapping 10. Tenth International Workshop on Human Gene Mapping
Cell Genet, 51 (1989), pp. 563-611
5.
D.H. Ledbetter,W.K. Cavenee
Molecular cytogenetics: interface of cytogenetics and monogenic disorders
The metabolic basis of inherited disease, 6, pp. 343-371
6.
H.S. Harrar,S. Jeffery,M.A. Patton
Linkage analysis in blep-harophimosis-ptosis syndrome confirms localisation to 3q21-24
J Med Genet, 32 (1995), pp. 774-777
7.
M.W. Thompson,R.R. McInnes,H.F. Willard
Variación gené-tica, polimorfismo y mutación
Genética en medicina, 4, pp. 111-135
8.
P. Amati,P. Gasparini,J. Zlotogora,J. Zelante,J.C. Chomet,A. Kitzis
A gene for premature ovarian failure associated with eyelid malformation maps 3q22-q23
Am J Hum Genet, 58 (1996), pp. 1089-1092
9.
M.W. Thompson,R.R. McInnes,H.F. Willard
Citogenética clí-nica: principios generales y anomalías autosómicas
Genética en medicina, 4, pp. 191-218
10.
C.T. Lawson,A. Fryer,M.J.M. Carette,G.M. Taylor,Y. Fukushima
Definition of the blepharophimosis, ptosis, epicanthus inversus syndrome critical region at chromosome 3q23 based on the analysis of chromosomal anomalies
Hum Mol Genet, 4 (1995), pp. 963-967
11.
M. Maw,B. Kar,J. Bisws,P. Bisws,D. Nancarrow,R. Bridges
Linkage of blepharophimosis syndrome in a large Indian pedigree to chromosome 7p
Hum Mol Genet, 5 (1996), pp. 2049-2054
12.
K.W. Wright,P.H. Spiegel
Malformaciones y lesiones de los párpados
Oftalmología pediátrica y estrabismo. Los requisitos en Oftalmología, pp. 11-18
13.
J.J. Kauski
Trastornos de los párpados
Oftalmología clínica, 4, pp. 1-37
14.
J.J. Kanski,K.K. Nischal
Los párpados
Atlas de oftalmología. Signos clínicos y diagnóstico diferencial, pp. 1-41
15.
J.J. Kanski,K.K. Nischal
Enfermedades sistémicas raras
Atlas de oftalmología. Signos clínicos y diagnóstico diferencial, pp. 427-468
16.
M.E. Wilson,R.W. Johnson
Congenital ptosis: long-term results of treatment using lyophilisedo fascia lata for frontalis suspensions
Ophthalmology, 98 (1991), pp. 1234-1237
17.
C.D. Mc Cord Jr.
The correction of telecanthus and epicant-hal folds
Ophthalmic Surg, 11 (1980), pp. 446-456
18.
N. Owens,R. Hadley,H. Kloepler
Hereditary blepharophi-mosis, ptosis and epicanthus inversus
J Int Coll Surg, 33 (1960), pp. 558-574
19.
R. Kohn,P.E. Romano
Blepharoptosis, blepharophimosis, epicanthus inversus and telecanthus: a syndrome with no ame
Am J Ophthalmol, 72 (1971), pp. 625-632
20.
P.L. Townes,E.K. Muechler
Blepharophimosis, ptosis, epi-canthus inversus and primary amenorrhea. A dominant trait
Arch Ophtalmol, 97 (1979), pp. 1664-1666
21.
R.M. Goodman,R.J. Gorlin
Síndrome de blefarofimosis-pto-sis
Malformaciones en el lactante y en el niño. Guía ilustrada, pp. 220-221
22.
M. Morales,D. Chardonnens,A. Bottani,M. Gersbach-Forrer,A. Campana
Le syndrome du blépharophimosis-ptosis-epicanthus inversus associé à une stérilité
J Gynecol Obstet Biol Reprod, 28 (1999), pp. 833-837
23.
I.S. Fraser,R.P. Shearman,A. Smith,P. Russell
An association between blepharophimosis, resistant ovary syndrome and true premature menopause
Fertil Steril, 50 (1988), pp. 747-751
24.
A. Smith,I.S. Fraser,R.P. Shearman,P. Russell
Blepharophimosis plus ovarian failure: a likely candidate for contiguous gene syndrome
J Med Genet, 26 (1989), pp. 434-438
25.
G.S. Jones,M.D. Ruehsen
Anew síndrome of amenorrea in association with hypergonadotrophism and apparently normal ovarian follicular apparatus
Am J Obstet Gynecol, 104 (1969), pp. 597-602
26.
J. Van Campenhout,B. Vauclair,K. Maraghi
Gonadotropin-resistant ovaries in primary amenorrhea
Obstet Gynecol, 40 (1972), pp. 6-11
27.
M.E. Escobar,S.B. Cigorraga,V.A. Chiauzzi,E.H. Charreau,M.A. Rivarola
Development of the gonadotrophic resistant ovary syndrome in myasthenia gravis: sugestión of similar autoimmune mechanisms
Acta Endocrinol, 99 (1982), pp. 431-436
28.
L.M. Talbert,M.H.G. Raj,M.G. Hammond,T. Greer
Endocrine and inmunologic studies in a patient with resistant ovary syndrome
Fertil Steril, 42 (1984), pp. 741-746
29.
H.T. Lin,A.E. Meiders,L.D. De Haan,F.B. Bronkhorst
Anovulation presumably due to the gonadotrophin-resistant ovary syndrome
Eur J Obstet Gynecol Reprod Biol, 16 (1984), pp. 327-332
30.
R.I. Tozzini
El ovario en la esterilidad
Esterilidad e infertilidad humanas, 2, pp. 156-249
31.
E. Pérez Peña
Factor ovárico.
Infertilidad, esterilidad y endocrinología de la reproducción. Un enfoque integral, pp. 419-465
32.
L. Speroff,R.H. Glass,N.G. Kase
Amenorrea
Endocrinología ginecológica e infertilidad, pp. 421-485
33.
K. Aittomäki,J.L. Diéguez Lucena,P. Pakarinen,P. Sistonen,L. Tapanainein,J. Gromoll
Mutationen in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure
Cell, 82 (1995), pp. 959-962
34.
K. Aittomäki,R. Herva,U.H. Stenman,K. Juntunen,P. Ylöstalo,O. Hovatta
Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene
J Clin Endocrinol Metab, 81 (1996), pp. 3722-3726
35.
B. Delon,H. Lallaoui,C. Abel-Lablanche,A. Geneix,V. Bellec,M. Benkhalifa
Fluorescent in-situ hybridization and sé-quense-tagged sites for delineation of an X:Y translocation in a patient with secondary amenorrhea
Mol Hum Reprod, 3 (1997), pp. 439-443
36.
T.R. Johnson,E.P. Peterson
Gonadotropin induced pregnancy following «premature ovarian failure»
Fertil Steril, 18 (1979), pp. 440-447
37.
M.P. Platia,G. Bloomquist,R.F. Williams,G.D. Hodgen
Refractoriness to gonadotropin therapy. How to distinguish ovariam failure versus psendovarian resistance caused by neutralizing antibodies
Fertil Steril, 42 (1984), pp. 779-784
38.
C. Stton
The limitations of laparoscopic ovarian biopsy
J Obstet Gynaecol Br Commonwlth, 81 (1974), pp. 317-323
39.
AR. La menopausia precoz y su tratamiento hormonal. Arias
Rev Med Chil, 78 (1950), pp. 373-379
40.
C.B. Coulam,RJ. Premature menopause I. Etiology. Ryan
Am J Gynecol, 133 (1979), pp. 639-644
41.
R.W. Rebar,G.F. Erickson,SSC. Yen
Idiopathic premature ovarian failure
Obstet Gynecol, 67 (1986), pp. 604-606
42.
C.B. Coulam,S.C. Adamson,J.F. Annegers
Incidence of premature ovarian failure
Obstet Gynecol, 67 (1986), pp. 604-606
43.
M.M. Alper,P.R. Garner
Premature ovarian failure: its relationship to autoimmune disease
Obstet Gynecol, 66 (1985), pp. 27-30
44.
F.S. Cowchocki,J.L. McCabe,B.B. Montgomery
Pregnancy after corticosteroid administration in premature ovarian failure (polyglandular endocrinopathy syndrome
Am J Obstet Gynecol, 158 (1988), pp. 118-122
45.
Z. Blumenfeld,S. Halachmi,B.A. Peretz,Z. Shmuel,D. Golan,A. Maker
Premature ovarian failure –the prognostic application of autoimmunity on conception after ovulation induction
Fertil Steril, 59 (1998), pp. 750-755
46.
J.N. Anasti,M.R. Flack,J. Froelich,L.M. Nelson
The use of human recombinant gonadotropin receptors to search for in-munoglobulin G-mediated premature ovarian failure
J Clin Endocrinol Metab, 80 (1995), pp. 224-229
47.
O. Winqvist,G. Gebre-Medhin,J. Fustafsson,E.M. Ritzén,Ö Lundkvist,F.A. Karlsson
Identification of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure
J Clin Endocrinol Metab, 90 (1995), pp. 1717-1723
48.
Consortium Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy.
An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains
Nat Genet, 17 (1997), pp. 399-404
49.
A. Hoek,J. Schoemaker,H.A. Drexhage
Premature ovarian failure and ovarian autoimmunity
Endocr Rev, 18 (1997), pp. 107-111
50.
Y. Aubard,M.P. Teissier,M.H. Grandjean,Y. Le Meur,J.H. Baudet
Les ménopauses précoces
J Gynecol Obstet Biol. Reprod, 26 (1997), pp. 231-237
51.
L.C. Tejerizo López,A. Tejerizo García,M. Gómez Serrano
La menopausia precoz
Toko-Gin Pract, 59 (2000), pp. 17-38
52.
G.S. Conway,G. Kaltsas,A. Patel,M.C. Davies,H.S. Jacobs
Characterization of idiopathic premature ovarian failure
Fertil Steril, 65 (1996), pp. 337-341
53.
M. Nicolino,M. Bost,M. David,L. Chanssain
Familial blep-harophimosis: an uncommon marker of ovarian dysgenesis
J Pediatr Endocrinol Metab, 8 (1995), pp. 127-133
54.
D. Panidis,D. Rousso,D. Vavilis,S. Skiadopoulos,A. Kalogeropoulos
Familial blepharophimosis with ovarian disfunction
Hum Reprod, 9 (1994), pp. 2034-2037
55.
D. Kreiner,K. Droesch,D. Navot,R. Scott,Z. Rosenwaks
Spontaneous and pharmacologically induced remissions in patients with premature ovarian failure
Obstet Gynecol, 73 (1988), pp. 926-928
56.
M.V. Saver,R.J. Paulson
Oocyte and embryo donation
Curr Opin Obstet Gynecol, 7 (1995), pp. 193-198
57.
A. Vassalli,M.M. Matzuk,H.A. Gardner,K.F. Lee,R. Jaenisch
Activin/inhibinin beta B subunit gene disruption leads to defects in eyelid development and female reproduction
Gen Dev, 8 (1994), pp. 414-427
Copyright © 2003. Elsevier España, S.L.